Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)

Clinical trial NCT05998993 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05998993
Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

EGF-R Positive Non-Small Cell Lung Cancer Non Small Cell Lung Cancer EGFR Exon 19 Deletion EGFR Exon 21 Mutation EGFR G719X

Start date: 2023-11-01
Primary completion: 2026-11-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.